Drugs / CM PRP-HA
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT05076526 | Nov 2021 → Nov 2022 | osteoarthritis, knee | Singapore General Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CM PRP-HA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05076526 ↗ |
| Known as | Cellular Matrix | “Cellular Matrix platelet-rich-plasma with hyaluronic acid (CM PRP-HA)” NCT05076526 ↗ |
| Route | Other | “intra-articular injections” NCT05076526 ↗ |